XML 102 R28.htm IDEA: XBRL DOCUMENT
v3.26.1

Stockholders’ Equity (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2026
Equity [Abstract] |
Schedule of stock reserved for issuance | As of March 31, 2026 and December 31, 2025, the Company had reserved common stock, on an as-if converted basis, for issuance as follows (in thousands):
| March 31, 2026 |  | December 31, 2025
K2 Warrants | 170 |  |  | 170 |
Pre-Funded Warrants | 7,722 |  | 4,622
Stock options issued and outstanding from 2024, 2019 Equity Incentive Plan and Inducement Plan | 7,078 |  |  | 5,385 |
Shares available for future grant from 2024 Equity Incentive Plan and Inducement Plan | 877 |  |  | 975 |
Total | 15,847 |  |  | 11,152 |
The reserved common stock in the table above does not include (i) the number of shares of the Company’s common stock issuable upon conversion of the remaining amount of the Conversion Amount specified within the Amended Loan Agreement (see Note 4), (ii) the variable number of shares issuable pursuant to conversion of amounts funded under the Convertible Grant Agreement (see Note 4), and (iii) the variable number of shares issuable pursuant to terms of the asset purchase agreement, dated May 31, 2025, between the Company and Chase Therapeutics Corporation.

X
- Definition Schedule of Stock Reserved for Issuance + References No definition available. + Details
Name: | alto_ScheduleOfStockReservedForIssuanceTableTextBlock
Namespace Prefix: | alto_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration